Mutual of America Capital Management LLC Sells 198 Shares of Waters Co. (NYSE:WAT)

Mutual of America Capital Management LLC lowered its position in Waters Co. (NYSE:WAT) by 2.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 7,103 shares of the medical instruments supplier’s stock after selling 198 shares during the period. Mutual of America Capital Management LLC’s holdings in Waters were worth $2,635,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of the company. Kennebec Savings Bank bought a new stake in Waters during the third quarter valued at about $33,000. Bank of Jackson Hole Trust bought a new stake in Waters during the fourth quarter valued at about $34,000. Ashton Thomas Securities LLC bought a new stake in Waters during the third quarter valued at about $35,000. Fortitude Family Office LLC grew its holdings in Waters by 235.7% during the fourth quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier’s stock valued at $35,000 after purchasing an additional 66 shares during the period. Finally, R Squared Ltd bought a new stake in Waters during the fourth quarter valued at about $63,000. Institutional investors own 94.01% of the company’s stock.

Wall Street Analysts Forecast Growth

WAT has been the subject of several recent research reports. Scotiabank raised Waters from a “sector perform” rating to a “sector outperform” rating and boosted their price target for the company from $430.00 to $450.00 in a report on Thursday, February 13th. Bank of America lowered their price objective on Waters from $430.00 to $410.00 and set a “neutral” rating on the stock in a research report on Thursday, February 13th. JPMorgan Chase & Co. boosted their price objective on Waters from $380.00 to $390.00 and gave the company a “neutral” rating in a research report on Thursday. Sanford C. Bernstein upgraded Waters from a “market perform” rating to an “outperform” rating and set a $430.00 price objective on the stock in a research report on Friday, January 10th. Finally, Barclays upgraded Waters from an “underweight” rating to an “equal weight” rating and boosted their price objective for the company from $360.00 to $415.00 in a research report on Monday, February 10th. Eleven research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Waters presently has an average rating of “Hold” and an average target price of $391.07.

Waters Trading Up 1.6 %

WAT opened at $392.34 on Friday. The stock has a market cap of $23.31 billion, a price-to-earnings ratio of 36.63, a P/E/G ratio of 3.79 and a beta of 1.00. The stock’s 50 day moving average price is $390.27 and its 200-day moving average price is $368.33. Waters Co. has a one year low of $279.24 and a one year high of $423.56. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.65 and a current ratio of 0.94.

Waters (NYSE:WAT) last released its earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 EPS for the quarter, beating analysts’ consensus estimates of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%. On average, equities analysts forecast that Waters Co. will post 12.86 EPS for the current year.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.